Cargando…

Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation

Cyclic GMP-AMP (cGAMP) synthase (cGAS) is a major DNA sensor responsible for cytosolic DNA-mediated innate immune response. Inhibition of cGAS may be an effective strategy for treating autoimmune diseases such as Aicardi-Goutieres syndrome and systemic lupus erythematosus. Compound C (also known as...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Junzhong, Luo, Xuan, Tian, Shuoran, Zhang, Xing, Huang, Shanlu, Wang, Hanze, Li, Qiumei, Cai, Shaoli, Chen, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059800/
https://www.ncbi.nlm.nih.gov/pubmed/32180716
http://dx.doi.org/10.3389/fphar.2020.00088
_version_ 1783504122191806464
author Lai, Junzhong
Luo, Xuan
Tian, Shuoran
Zhang, Xing
Huang, Shanlu
Wang, Hanze
Li, Qiumei
Cai, Shaoli
Chen, Qi
author_facet Lai, Junzhong
Luo, Xuan
Tian, Shuoran
Zhang, Xing
Huang, Shanlu
Wang, Hanze
Li, Qiumei
Cai, Shaoli
Chen, Qi
author_sort Lai, Junzhong
collection PubMed
description Cyclic GMP-AMP (cGAMP) synthase (cGAS) is a major DNA sensor responsible for cytosolic DNA-mediated innate immune response. Inhibition of cGAS may be an effective strategy for treating autoimmune diseases such as Aicardi-Goutieres syndrome and systemic lupus erythematosus. Compound C (also known as Dorsomorphin) has been annotated as a potent and reversible inhibitor for AMPKs as well as ALK protein kinases. Here, we report a new function of Compound C which can suppress dsDNA-dependent type I interferon induction. These effects were not dependent on the activities of AMPK proteins. In vitro assays and liquid chromatograph-mass spectrometry data show that Compound C has the capability of reducing cGAMP accumulation, suggesting that Compound C may function as a modulator involved in the cGAS-STING-mediated DNA sensing pathway. Furthermore, Compound C is able to rescue the autoimmune phenotypes in a mouse model carrying the Trex1 gene deficiency. These data demonstrate a new and inverse correlation between Compound C and type I interferon production in response to dsDNA signaling.
format Online
Article
Text
id pubmed-7059800
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70598002020-03-16 Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation Lai, Junzhong Luo, Xuan Tian, Shuoran Zhang, Xing Huang, Shanlu Wang, Hanze Li, Qiumei Cai, Shaoli Chen, Qi Front Pharmacol Pharmacology Cyclic GMP-AMP (cGAMP) synthase (cGAS) is a major DNA sensor responsible for cytosolic DNA-mediated innate immune response. Inhibition of cGAS may be an effective strategy for treating autoimmune diseases such as Aicardi-Goutieres syndrome and systemic lupus erythematosus. Compound C (also known as Dorsomorphin) has been annotated as a potent and reversible inhibitor for AMPKs as well as ALK protein kinases. Here, we report a new function of Compound C which can suppress dsDNA-dependent type I interferon induction. These effects were not dependent on the activities of AMPK proteins. In vitro assays and liquid chromatograph-mass spectrometry data show that Compound C has the capability of reducing cGAMP accumulation, suggesting that Compound C may function as a modulator involved in the cGAS-STING-mediated DNA sensing pathway. Furthermore, Compound C is able to rescue the autoimmune phenotypes in a mouse model carrying the Trex1 gene deficiency. These data demonstrate a new and inverse correlation between Compound C and type I interferon production in response to dsDNA signaling. Frontiers Media S.A. 2020-02-28 /pmc/articles/PMC7059800/ /pubmed/32180716 http://dx.doi.org/10.3389/fphar.2020.00088 Text en Copyright © 2020 Lai, Luo, Tian, Zhang, Huang, Wang, Li, Cai and Chen http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Lai, Junzhong
Luo, Xuan
Tian, Shuoran
Zhang, Xing
Huang, Shanlu
Wang, Hanze
Li, Qiumei
Cai, Shaoli
Chen, Qi
Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation
title Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation
title_full Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation
title_fullStr Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation
title_full_unstemmed Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation
title_short Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation
title_sort compound c reducing interferon expression by inhibiting cgamp accumulation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059800/
https://www.ncbi.nlm.nih.gov/pubmed/32180716
http://dx.doi.org/10.3389/fphar.2020.00088
work_keys_str_mv AT laijunzhong compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation
AT luoxuan compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation
AT tianshuoran compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation
AT zhangxing compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation
AT huangshanlu compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation
AT wanghanze compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation
AT liqiumei compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation
AT caishaoli compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation
AT chenqi compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation